http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108998495-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-392 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108998495-B |
| titleOfInvention | A kind of high-throughput screening method of anti-breast cancer medicines |
| abstract | It is different from previous methods the present invention provides a kind of high-throughput screening method of anti-breast cancer medicines, accurate individualized treatment can be provided for cancer patient and select medicine.The survival rate of tumour cell can be improved by the concentration of amphotericin B and the gentamicin in control tumor cell culture liquid in the present invention, and cellular morphology is effectively maintained to promote absorption of the tumour cell to nutriment.Pass through the concentration of insulin and growth factor EGF in control tumor cell culture liquid, the growth rate of tumour cell can be improved, and improve cell activity, available a large amount of high activity tumour cell, the usage amount of fetal calf serum can be reduced using the insulin of the ratio and growth factor simultaneously, since fetal calf serum price is more expensive, usage amount reduction is conducive to economize on resources, and half-inhibitory concentration (IC50) error of the cell cultivated using the present invention for the medication of drug screening measurement is small, it is possible to reduce detection number. |
| priorityDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 205.